Best Pharmaceutical Stocks To Buy In 2024
vaccinesExplore Stocklytics' meticulously researched selection of the Best Pharmaceutical Stocks to Buy in 2023, focusing on companies within the pharmaceutical sector. These picks highlight pharmaceutical stocks involved in drug development, research, and healthcare innovations. Stocklytics identifies pharmaceutical stocks poised for growth, considering factors like drug pipelines, regulatory approvals, and market demand. Whether you're interested in therapeutic breakthroughs, medical research, or healthcare advancements, Stocklytics' selections offer opportunities to invest in companies driving innovation and potential breakthroughs in the pharmaceutical industry in the coming year.
| # | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 |  Eli Lilly & Co LLY | $760.00 | arrow_drop_down1.49% | $739.19B | 2.08MAVG.3.36M | 112.25 | Neutralremove | 0.67% | 74.34% | 75 | AI Analysis | ||||
| 2 | Cardinal Health CAH | $99.53 | arrow_drop_up1.49% | $23.73B | 1.72MAVG.2.40M | 44.03 | Neutralremove | 2.01% | 16.84% | 75 | AI Analysis | ||||
| 3 |  Gilead Sciences GILD | $65.96 | arrow_drop_up2.13% | $81.62B | 8.73MAVG.7.03M | 183.22 | Neutralremove | 4.71% | -15.55% | 72 | AI Analysis | ||||
| 4 |  CVS Health CVS | $55.82 | arrow_drop_up0.25% | $68.93B | 9.28MAVG.21.48M | 9.79 | Neutralremove | 4.77% | -19.92% | 68 | AI Analysis | ||||
| 5 |  McKesson MCK | $559.90 | arrow_drop_up0.86% | $69.49B | 636.90KAVG.948.53K | 25.01 | Sellkeyboard_arrow_down | 0.44% | 41.94% | 66 | AI Analysis | ||||
| 6 |  Bristol-Myers Squibb Co BMY | $44.94 | arrow_drop_up0.44% | $88.52B | 8.69MAVG.12.70M | - | Neutralremove | 5.47% | -34.38% | 65 | AI Analysis | ||||
| 7 |  Johnson & Johnson JNJ | $149.91 | arrow_drop_up0.04% | $357.92B | 5.71MAVG.7.67M | 22.24 | Buykeyboard_arrow_up | 3.34% | -7.26% | 62 | AI Analysis | ||||
| 8 |  Amgen AMGN | $310.14 | arrow_drop_down0.86% | $161.09B | 2.61MAVG.3.58M | 44.30 | Neutralremove | 3.00% | 32.48% | 60 | AI Analysis | ||||
| 9 |  Pfizer PFE | $28.01 | arrow_drop_down0.60% | $157.24B | 25.81MAVG.54.38M | - | Neutralremove | 6.05% | -26.86% | 55 | AI Analysis |
About Best Pharmaceutical Stocks To Buy In 2024
Explore Stocklytics' meticulously researched selection of the Best Pharmaceutical Stocks to Buy in 2023, focusing on companies within the pharmaceutical sector. These picks highlight pharmaceutical stocks involved in drug development, research, and healthcare innovations. Stocklytics identifies pharmaceutical stocks poised for growth, considering factors like drug pipelines, regulatory approvals, and market demand. Whether you're interested in therapeutic breakthroughs, medical research, or healthcare advancements, Stocklytics' selections offer opportunities to invest in companies driving innovation and potential breakthroughs in the pharmaceutical industry in the coming year.
Discover the Power of Stocklytics Tools
Our suite of tools empowers you to make informed decisions, seize opportunities, and stay ahead in the competitive trading world.
See Stocklytics Tools
Sign up for our newsletter
Join our exclusive community of over one million investment enthusiasts and receive our free newsletter filled with analysis, news, and updates every weekday.